Skip to content
All case studies
  • Diagnostics

Identifying 39 pharma partnership opportunities to shape a world-leading diagnostics company’s 5-year assay pipeline

What we did:

  • Our diagnostics client’s objective was to be more proactive to identify partnership opportunities with pharma companies who would benefit from new SDx and CDx assays.

  • We identified opportunities through review of trial registries/ results, protocols, conference presentations, and peer-reviewed literature.

Impact:

  • Identified 39 opportunities across 19 distinct biomarkers.

  • Opportunities mapped to 26 pharma assets from seven large pharma companies.

  • Informed the client's IVD assay pipeline for the next 5 years.

More in Diagnostics

View all case studies

Accelerate the adoption of your health innovation.

Get in touch